Skip to content
CJC Ipa Direct A mechanism-first reading of the CJC-1295 and ipamorelin literature — two GH secretagogues, two receptors, and what the studies actually measured.

What researchers tested in people

What has CJC-1295 Ipamorelin research proved?

Separate tests explain the idea. A health gain from the mixed vial remains unproved.

What the research proves and still can't answer

What does CJC-1295 Ipamorelin research tell you? In 1 clear finding, both drugs pushed growth hormone up when tested alone. CJC-1295 also raised a liver protein used for cell growth. Researchers haven't tried the pair in people.

The reason for pairing them comes from older work with other drugs. Those drugs gave the growth gland two different orders. Putting both orders together led to a bigger rise. That work says nothing about better health.

The studies give us changed blood tests. The sales claims promise sleep, muscle, recovery, and fat loss.

No well-run people study links the mixed vial to those gains.

Whether you would benefit is still unknown.

What each drug makes the growth gland do

The two drugs give different orders to the growth gland under your brain. CJC-1295 copies the brain's command for making growth hormone and sending it into blood. Ipamorelin copies an order from ghrelin, the hunger hormone. Both orders reach the same gland.

CJC-1295 makes the gland produce more growth hormone. Ipamorelin frees hormone already stored there. It may also weaken the gland's stop order.

The liver then makes a protein that supports cell growth and affects muscle and fat. That protein also helps tell the gland when enough growth hormone has been released. In 1 review from 2025, the writers explain how the long drug does this [13].

Two different orders may produce a larger rise in growth hormone. They don't show whether safety improves or whether you would feel better.

What each drug makes the growth gland do

What cjc-1295 ipamorelin studies found with two signals

An older people study gave two related drugs to 18 healthy men. One drug amount was 1 microgram for each kilogram of a man's weight. A million of those micrograms would make one gram, but you don't need to work it out. The figure only records what researchers gave. Together, the drugs pushed growth hormone beyond the expected rise [3].

The study didn't use CJC-1295 with ipamorelin. It showed that two different orders to the growth gland can add to each other.

In 2002, researchers put both related drugs on grown cells. The cells made nearly twice the amount of the chemical being counted [4]. That explains CJC-1295 paired with ipamorelin. It can't show whether a person would feel better.

For ipamorelin cjc 1295, what does each drug change?

Each drug in ipamorelin cjc 1295 acts for a different time. In 1 group of animal tests, ipamorelin gave a short rise in growth hormone. Researchers used an older drug called growth-hormone-releasing peptide 6 for comparison. They gave ipamorelin at more than 200 times the amount that had already raised growth hormone. Even then, the 2 stress hormones they checked did not rise [2].

The test against growth-hormone-releasing peptide 6 did not show how long either drug acted. CJC-1295 supplies the long effect. In healthy adults, 1 CJC-1295 shot under the skin made growth hormone reach at least 2 times its start. The high point was no more than ten times the start. A liver-made protein tied to growth stayed high for 9 to 11 days. Added shots kept that protein high as late as 28 days [1].

These separate results give researchers a reason to test the mix.

They don't show what CJC-1295 with ipamorelin does to people. That claim remains unproved.

What cjc 1295 and ipamorelin may change between natural rises

In 1 study, long-acting CJC-1295 did not stop the body's usual rises in growth hormone. Healthy men had the same number of rises at the same times. Growth hormone stayed higher between them. The average level rose 46%. A liver-made protein tied to growth rose 45%. For every kilogram a man weighed, he got either 60 or 90 micrograms [9]. Those are study records, not a personal amount.

The test eased one concern about CJC-1295 alone. The long drug didn't wipe out the body's usual pattern. It says nothing about what cjc 1295 and ipamorelin do together.

A separate test did not use either drug. It found more natural growth-hormone rises during each 24 hours of fasting [10]. That tells us the body can change the timing on its own. The cjc 1295 dac page explains how the long form may keep blood levels high between those rises.

What tests of other drugs do not tell you about cjc ipamorelin

Tests of other drugs may give researchers new questions about cjc ipamorelin. They can't show what this pair does.

In 1 rat study, an unrelated drug helped the bowel start moving after an operation. The paper calls it TZP-101. The largest test amount was 1 milligram for each kilogram of rat weight. The rats passed bowel waste sooner [11]. A second rat test found more change in the stomach than in the small bowel [12]. Those bowel findings don't help you judge this pair.

In 2026, 1 review covered 5 tesamorelin tests. That drug is not part of this pair. Scans showed less deep belly fat and less liver fat. Total weight from muscle, bone, organs, and body water rose, but the test did not separate those parts. A liver-made growth protein also rose. No serious harm appeared, and blood sugar didn't change [7]. The review doesn't say whether people felt better. It gives no direct answer about this pair.

In 2024, a fish test found sex-hormone changes after ipamorelin [14]. Fish work can raise a research question. It can't tell an older man what will happen to him.

What no people study has measured yet

The main CJC-1295 answer is still missing. Only 1 kind of test can answer it: a people study using both drugs and a similar group not using them. None exists. We don't know the total hormone rise, how long it lasts, or how often harm occurs.

Cells in a dish made more of a measured chemical when two related drugs were present [4]. Men also had a larger growth-hormone rise after two older drugs [3]. Those findings show that two gland signals can add up. They don't show the benefits or harms of this exact vial.

The verdict is plain: benefit and safety haven't been proved.

The supporting studies used separate drugs or close relatives. They didn't test the mixed vial being sold.